INTECH Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

INTECH Investment Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.22M	Sell	81,071 -30,350	-27%	-$530K	0.01%	936
2026 Q1	$2.14M	Buy	111,421 +84,050	+307%	+$1.83M	0.02%	677
2025 Q4	$602K	Sell	27,371 -46,122	-63%	-$832K	0.01%	1406
2025 Q3	$892K	Buy	73,493 +26,150	+55%	+$354K	0.01%	1236
2025 Q2	$882K	Sell	47,343 -3,136	-6%	-$62.1K	0.01%	1271
2025 Q1	$967K	Buy	50,479 +21,821	+76%	+$639K	0.01%	1215
2024 Q4	$1.03M	Buy	28,658 +10,322	+56%	+$349K	0.01%	1116
2024 Q3	$778K	Buy	18,336 +11,173	+156%	+$474K	0.01%	958
2024 Q2	$289K	Buy	+7,163	New	+$299K	﹤0.01%	964

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

INTECH Investment Management's TNDM Position: Q2 2026 in Review

INTECH Investment Management reduced its Tandem Diabetes Care (TNDM) stake by 27% in Q2 2026, selling an estimated $530K and leaving 81,071 shares worth $1.22M. The position accounts for 0.01% of the portfolio, ranked #936.

INTECH Investment Management first reported a position in TNDM in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.14M in Q1 2026. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

INTECH Investment Management held 81,071 shares of Tandem Diabetes Care worth $1.22M as of Q2 2026.
INTECH Investment Management sold 30,350 Tandem Diabetes Care shares in Q2 2026, an estimated $530K.
Tandem Diabetes Care made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #936 holding.
INTECH Investment Management first reported a position in Tandem Diabetes Care in Q2 2024 and has held it in 9 quarters since.
INTECH Investment Management's Tandem Diabetes Care position peaked at $2.14M in Q1 2026.
274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.